Title : Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.

Pub. Date : 2018 Nov

PMID : 30353044






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Olaparib (Lynparza ) is a PARP inhibitor approved for advanced BRCA-mutated (BRCAm) ovarian cancer. olaparib collagen type XI alpha 2 chain Homo sapiens